MLSS News and Press, Milestone Scientific Inc.

2026-07-01 08:51:07 ET More on Milestone Scientific Milestone Scientific Inc. (MLSS) Q1 2026 Earnings Call Transcript Seeking Alpha’s Quant Rating on Milestone Scientific Historical earnings data for Milestone Scientific Financial information for Miles...

Medical Segment Momentum Accelerates, Posting 300% Growth Versus Q2 2025 Company to Showcase Technology at American Society of Pain & Neuroscience Conference in Miami Beach, July 16–18, Alongside Board Member and ASPN Co-Founder and Vice Chairman, Dr. Dawood Sayed ROSELAND, N.J....

ROSELAND, N.J., June 25, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced a series of strategic governance initiatives designed to support the Company’...

ROSELAND, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments utilizing Dynamic Pressure Sensing™ (DPS) technology, today highlighted the continued growth in clinical adoption and physician ac...

2026-05-14 11:30:43 ET Milestone Scientific Inc. (MLSS) Q1 2026 Earnings Call May 14, 2026 8:30 AM EDT Company Participants Eric Hines - Chief Executive Officer, President & Director Keisha Harcum - Vice President of Finance ... Read the full article on See...

Operating Loss Reduced As Company Advances Toward Profitability Reaffirms Outlook for Double-Digit Revenue Growth in 2026, including Significant Growth in CompuFlo® Sales ROSELAND, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of co...

2026-05-14 07:18:22 ET More on Milestone Scientific Milestone Scientific Inc. (MLSS) Q4 2025 Earnings Call Transcript Milestone Scientific outlines $9.8M-$10.2M 2026 revenue plan while targeting cash flow breakeven in early 2027 Milestone Scientific misses top-line e...

ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May ...

ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments, today provided an update on the expansion of its CompuFlo® medical business, highlighting increasing physician utilization, expanding clinic...

ROSELAND, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the closing of a $2.15 million private placement of common stock and warr...